EC Orthopaedics

In osteo-articular, the PRP remains a technique of choice and first intention for a large number of pathologies. And this despite discrepancy in the published results. Efforts are still in progress to try to find the elements behind this variability. The presence of the anticoagulant which can interfere with the activity of the platelets can be an inhibitory element. Therefore, washed platelet concentrates characterized by a total absence of anti-coagulant were used. The results are very promising particularly in knee osteoarthritis.

 Keywords: Washed Platelet Concentrates; PRP; Knee Osteoarthritis

1. Marcia G Tonnesen., et al. “Angiogenesis in wound healing”. Journal of Investigative Dermatology Symposium Proceedings 1 (2000): 40-46.
2. Tony G Walsh., et al. “The functional role of platelets in the regulation of angiogenesis”. Platelets3 (2015): 199-211.
3. Elisabeth M Battinelli. “The role of platelets in angiogenesis”. Platelets (Fourth Edition) (2019): 433-441.
4. M Monchi and V Manda. “Physiopathologie de l’anticoagulation au citrate”. Symposia/Transfusion Clinique et Biologique4 (2015): 183-200.
5. Anggraini Margono., et al. “The effect of calcium gluconate on platelet rich plasma activation for VEGF-A expression of human dental pulp stem cells”. European Journal of Dentistry 2 (2022): 424-429.
6. Surena Vahabi., et al. “Comparison of the effect of activated or non-activated PRP in various concentrations on osteoblast and fibroblast cell line proliferation”. Cell and Tissue Banking 3 (2017): 347-353.
7. Paula Oneto., et al. “Anticoagulants interfere with the angiogenic and regenerative responses mediated by platelets”. Frontiers in Bioengineering and Biotechnology 8 (2020): 223.
8. Helge Schoenfeld., et al. “Platelet activity in washed platelet concentrates”. Anesthesia and Analgesia 1 (2004): 17-20.
9. Helge Schoenfeld., et al. “The functional integrity of platelets in volume-reduced platelet concentrates”. Anesthesia and Analgesia 1 (2005): 78-81.
10. W H Dzik. “Platelet suspensions and methods the preparation of platelet concentrates by the light-spin/hard-spin technique”. Transfusion Science3 (1991): 171-181.
11. Béatrice Hechler., et al. “Platelet preparation for function testing in the laboratory and clinic: Historical and practical aspects”. Research and Practice in Thrombosis and Haemostasis 4 (2019): 615-625.
12. Amanda GM Perez., et al. “Relevant aspects of centrifugation step in the preparation of platelet-rich plasma”. ISRN Hematology (2014): 176060.
13. Jean-Pierre Cazenave., et al. “Preparation of washed platelet suspensions from human and rodent blood”. Methods in Molecular Biology 272 (2004): 13-28.
14. , et al. “Platelet suspensions and methods for resuspending platelet”. United States Patent.
15. PF van der Meer., et al. “Aggregates in platelet concentrates”. Vox Sanguinis 1 (2015): 96-100.
16. J Ringwald., et al. “Residual aggregates in platelet products: what do we know?” Vox Sanguinis 3 (2014): 209-218.
17. PW Braunstein., et al. “Platelets, fibroblasts, and inflammation: tissue reactions to platelets injected subcutaneously”. American Journal of Pathology 1 (1980): 53-66.
18. Andrey Skripchenko., et al. “A rest period before agitation may improve some in vitro apheresis platelet parameters during storage”. Transfusion 7 (2012): 1433-1438.
19. Marco Cattaneo., et al. “Platelet aggregation studies: autologous platelet-poor plasma inhibits platelet aggregation when added to platelet-rich plasma to normalize platelet count”. Haematologica5 (2007): 694-697.